St. Louis is in the midst of a renaissance.
We invite you to read the first edition of The Sequence, our new newsletter dedicated to the ideas, opportunities, and innovations shaping the future of our region.
As we mark 25 years of BioSTL, we find ourselves at an inflection point. By combining our strengths in agtech and human health, we're driving billions of dollars of impact on St. Louis' GDP, and the momentum is clear.
Inside this issue:
- Conversation with Jim McCarter: an introduction to our first for-profit venture studio
- Innovation Framework: early details on the upcoming Breakthrough Report
The best chapters of St. Louis' story are yet to be written, and we want you to be part of them.
Subscribe to receive The Sequence today: https://www.biostl.org/contact#email-subscribe
Read More at